Nuvectis Pharma, Inc. (NVCT)
23.99
+1.50
(+6.67%)
USD |
NASDAQ |
Sep 11, 16:00
23.93
-0.06
(-0.25%)
After-Hours: 20:00
Nuvectis Pharma Price to Book Value : 70.51 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 70.51 |
| September 10, 2026 | 66.10 |
| September 09, 2026 | 66.96 |
| September 08, 2026 | 70.51 |
| September 04, 2026 | 71.98 |
| September 03, 2026 | 71.63 |
| September 02, 2026 | 70.31 |
| September 01, 2026 | 67.78 |
| August 31, 2026 | 66.81 |
| August 28, 2026 | 69.75 |
| August 27, 2026 | 74.04 |
| August 26, 2026 | 73.48 |
| August 25, 2026 | 76.10 |
| August 24, 2026 | 70.16 |
| August 21, 2026 | 69.25 |
| August 20, 2026 | 68.63 |
| August 19, 2026 | 68.57 |
| August 18, 2026 | 61.46 |
| August 17, 2026 | 56.08 |
| August 14, 2026 | 55.73 |
| August 13, 2026 | 56.52 |
| August 12, 2026 | 57.43 |
| August 11, 2026 | 57.05 |
| August 10, 2026 | 55.48 |
| August 07, 2026 | 55.70 |
| Date | Value |
|---|---|
| August 06, 2026 | 55.35 |
| August 05, 2026 | 56.61 |
| August 04, 2026 | 59.08 |
| August 03, 2026 | 63.49 |
| July 31, 2026 | 63.25 |
| July 30, 2026 | 66.90 |
| July 29, 2026 | 60.81 |
| July 28, 2026 | 58.26 |
| July 27, 2026 | 57.43 |
| July 24, 2026 | 56.76 |
| July 23, 2026 | 59.23 |
| July 22, 2026 | 56.70 |
| July 21, 2026 | 56.08 |
| July 20, 2026 | 53.00 |
| July 17, 2026 | 56.26 |
| July 16, 2026 | 54.67 |
| July 15, 2026 | 57.58 |
| July 14, 2026 | 53.76 |
| July 13, 2026 | 54.20 |
| July 10, 2026 | 53.94 |
| July 09, 2026 | 55.82 |
| July 08, 2026 | 55.11 |
| July 07, 2026 | 56.43 |
| July 06, 2026 | 57.70 |
| July 02, 2026 | 57.52 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Decoy Therapeutics, Inc. | 0.3287 |
| Unicycive Therapeutics, Inc. | 2.766 |
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
| Anika Therapeutics, Inc. | 2.034 |
Price to Book Value Related Metrics
| PEG Ratio | -1.387 |
| Price | 23.99 |
| Earnings Yield | -5.33% |
| Market Cap | 640.41M |
| PEGY Ratio | -1.387 |